Table 3.
Variable | Outcome | Female | Male | Total | Sig. |
---|---|---|---|---|---|
Doses | One | 252 (48.1%) | 128 (50.2%) | 380 (48.8%) | 0.581 |
Two | 272 (51.9%) | 127 (49.8%) | 399 (51.2%) | ||
Interval | days | 28.01 ± 3.02 | 27.50 ± 3.34 | 27.85 ± 3.13 | 0.741 |
Infection | Yes | 52 (9.9%) | 24 (9.4%) | 76 (9.8%) | 0.821 |
Chi-squared test and ANOVA test were used with a significance level (Sig.) of ≤0.05.